Construction of Gynecological Tumor Sample Library

NCT06204354 | Not Yet Recruiting

• 1 other identifier: Construction of tumor sample
• Study Type: observational
• Target: 2,500
• Locations: 0 countries
• Sites: N/A

Brief Summary

Constructing a gynecological tumor samples library, which is open and can be accessed.

Conditions

Gynecologic Cancer

Outcome Measures

Primary Outcomes (1)

• construction of Biobank

  Biobank including gynecolgic cancer samples, including cervical cancer, endometrial cancer, ovarian cancer, vulva cancer, vaginal cancer, and others types

  3 years

Secondary Outcomes (2)

• Exploring the molecular mechanism based on biobank

  3 year

• Drug sensitivity detection based on biobank

  3 year

Study Arms (6)

samples of cervical cancer

fresh samples collected from patients diagnosed with cervical cancer

samples of endometrial cancer

fresh samples collected from patients diagnosed with endometrial cancer

samples of ovarian cancer

fresh samples collected from patients diagnosed with ovarian cancer

samples of vulva cancer

fresh samples collected from patients diagnosed with vulva cancer

samples of vaginal cancer

fresh samples collected from patients diagnosed with vaginal cancer

samples of rare gynecological cancer

fresh samples collected from patients diagnosed with rare gynecological cancer

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients diagnosed with gynecologic cancer, including cervical cancer, endometrial cancer, ovarian cancer, vulva cancer, vaginal cancer, and other rare type gynecologic cancer.

You may qualify if:

• An informed consent form was obtained. If the age is less than 18 years old, the consent form should be signed by the guardian.
• Preoperative tumor burden assessment and intraoperative evaluation by the supervising physician (professor) suggest sampling is acceptable.
• The research team believes that sampling is possible.
• Having the relevant requirements for sample library storage.
• Surgical treatment is performed at Peking Union Medical College Hospital.

You may not qualify if:

• The research team considers any circumstances or considerations that may hinder normal pathological evaluation.

Sponsors & Collaborators

• Peking Union Medical College Hospital: lead

Biospecimen

Retention: SAMPLES WITH DNA

Fresh samples from gynecological cancer, including cervical cancer, ovarian cancer, endometrial cancer, vulva cancer, vaginal cancer, and some other rare type of cancer.

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 22, 2023
• First Posted: January 12, 2024
• Study Start: January 1, 2024
• Primary Completion (Estimated): January 1, 2027
• Study Completion (Estimated): January 1, 2027
• Last Updated: January 12, 2024

Record last verified: 2023-12